Analysis of septic biomarker patterns: prognostic value in predicting septic state

Area of Science:

• Biochemistry
• Immunology
• Critical Care Medicine

Background:

• Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection.
• Distinguishing between infection, sepsis, severe sepsis, and septic shock is clinically challenging.
• Accurate early diagnosis is crucial for timely and effective treatment to improve patient outcomes.

Purpose of the Study:

• To compare serum biomarker levels and clinical symptoms in patients with varying stages of sepsis and healthy controls.
• To identify specific biomarkers capable of differentiating between infection, sepsis, severe sepsis, and septic shock.
• To evaluate the utility of a combined clinical and biomarker algorithm for predicting sepsis severity.

Main Methods:

• Assay of 15 serum biomarkers in patients with infection, sepsis, severe sepsis, septic shock, and healthy controls.
• Analysis of both pro-inflammatory and anti-inflammatory cytokines.
• Development and application of a top scoring pair algorithm integrating clinical and biomarker data.

Main Results:

• Nine biomarkers were detectable in patients, and four in controls.
• No single biomarker could differentiate the three sepsis severity levels (sepsis, severe sepsis, septic shock).
• Interleukin-1 receptor antagonist (IL-1ra) showed the best sensitivity and specificity for differentiating septic shock.
• Interleukin-6 (IL-6) differentiated infected patients from those with sepsis.
• IL-1ra, IL-6, IL-8, and monocyte chemoattractant protein 1 differentiated septic shock from earlier stages but not sepsis from severe sepsis.
• The combined algorithm accurately diagnosed sepsis patients likely to progress to a more severe state.

Conclusions:

• Individual biomarkers have limitations in differentiating sepsis severity.
• IL-6 is valuable for distinguishing infection from sepsis.
• A multi-biomarker and clinical data approach, particularly the top scoring pair algorithm, offers potential for improved sepsis diagnosis and outcome prediction.